NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Norco? Mail in a sample (US only) and let us test it.

Test my supply
73%
Finnrick rating
#265 of 500 ranked vendors
15 of 21 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Norco's purity-focus record is strongest in Retatrutide, where recent high-purity, near-label fills offset earlier identity and fill misses, with Tirzepatide also improving after a poor early lot. BPC-157 has turned down on recent low-purity samples, GHK-Cu is thin and split, and batch gaps plus uneven fills keep the evidence dispersed.

methodology →
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.04
82%
2
2
Retatrutide
$0.90
80%
12
3
Tirzepatide
$0.58
76%
3
4
BPC-157
-
50%
4
6
NAD+
$0.01
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Jul 2026: 80%20 Jul 2026: 80%4 Aug 2026: 84%4 Aug 2026: 85%4 Aug 2026: 86%9 Aug 2026: 86%12 Aug 2026: 75%13 Aug 2026: 75%27 Aug 2026: 75%7 Sep 2026: 75%7 Sep 2026: 74%7 Sep 2026: 74%7 Sep 2026: 73%7 Sep 2026: 72%24 Sep 2026: 73%24 Sep 2026: 73%21 Oct 2026: 73%23 Oct 2026: 73%28 Oct 2026: 73%30 Oct 2026: 73%2 Nov 2026: 73%17 Nov 2026: current 73%80%75%73%Jul 26Nov 26
Peptide testing

Ordered peptides from Norco? Mail in a sample (US only) and let us test it.

Test my supply
Norco test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
2 Nov 2026
Fail
BPC-157
lab nameView COA
30 Oct 2026
Pass
Retatrutide
lab nameView COA
28 Oct 2026
Pass
Retatrutide
lab nameView COA
23 Oct 2026
Pass
Tirzepatide
lab nameView COA
21 Oct 2026
Fail
BPC-157
lab nameView COA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Pass
BPC-157
lab nameView COA
7 Sep 2026
Fail
Retatrutide
lab nameView COA
7 Sep 2026
Fail
Retatrutide
lab nameView COA
7 Sep 2026
Fail
GHK-Cu
lab nameView COA
1-10 of 21

About Norco test results from Finnrick

Norco is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 21 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Norco peptides in this dataset are BPC-157 (4 tests), GHK-Cu (2 tests) and Retatrutide (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 21 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Norco? Mail in a sample (US only) and let us test it.

Test my supply